纳米载体用于大麻素输送:增强治疗潜力
Varun Singh1, Samar Vihal2, Rupali Rana1
1Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, Punjab, 143005, India.
Recent advances in drug delivery and formulation
|October 2, 2024
概括
纳米技术为医用大麻交付挑战提供了解决方案. 在纳米载体中封装大麻素可以提高生物可用性,溶解性和有针对性的分布,以增强治疗效果.
科学领域:
- 药理学 药理学是指药理学的学科.
- 纳米技术纳米技术
- 药用化学 医学化学
背景情况:
- 医用大麻显示出治疗疼痛,焦虑,抑郁和神经系统疾病的治疗潜力.
- 植物大麻素是关键的活性化合物,但它们的复杂性阻碍了有效的药用.
- 挑战包括与传统大麻药物的生物可用性不一致,溶解性差,以及吸收问题.
研究的目的:
- 审查纳米技术应用的研究和专利,以改善医用大麻的输送.
- 确定纳米载体如何应对大麻素的生物可用性,溶解性和受控释放方面的挑战.
- 综合纳米技术在增强大麻治疗方面的潜力方面的发现.
主要方法:
- 对36篇研究论文和19项与大麻纳米技术相关的专利进行了全面审查.
- 对研究的分析,重点是纳米载体对大麻素的封装技术.
- 评估报告中的生物可用性,释放特征,溶解性和稳定性的改善.
主要成果:
- 在36篇审查的论文中,7篇报告了大麻化合物的增强生物可用性.
- 几篇论文和专利重点是使用纳米载体改善药物释放,溶解度和稳定性.
- 分析的19项专利详细介绍了大麻成分有效的纳米载体封装方法.
结论:
- 纳米技术为克服医用大麻管理的局限性提供了一个有希望的解决方案.
- 纳米载体系统可以显著提高大麻素的生物可用性,溶解性和向输送.
- 这种方法促进了基于大麻的疗法中的创新干预和精准医学.
相关概念视频
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
203
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
203
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
167
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
167